HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sodium and guanine nucleotide regulation of dopamine receptor agonist and antagonist binding sites in MtTW15 pituitary tumors.

Abstract
The modulation of the dopamine receptor in MtTW15 tumors was investigated. The antagonist dopaminergic binding site in MtTW15 tumors labelled with [3H]spiperone remains unchanged at 25 degrees C in the presence or absence of sodium or guanine nucleotides (Gpp(NH)p); by contrast at 37 degrees C sodium increases the affinity while Gpp(NH)p decreases it slightly. The dopamine receptor in this tumor, such as the intact adenohypophysis, exists in a high and low affinity state for dopamine agonists. These agonist affinity states evaluated with apomorphine competition for [3H]spiperone binding show similar affinities as those of intact tissue but have a lower proportion of the high affinity state. At 25 degrees C, a partial conversion of the high into the low affinity state is obtained in the presence of both sodium and Gpp(NH)p, while at 37 degrees C a complete conversion is observed. These data show differences in the modulation of antagonist and agonist dopaminergic binding sites in MtTW15 pituitary tumors compared with the intact pituitary.
AuthorsT Di Paolo, D Lévesque
JournalCanadian journal of physiology and pharmacology (Can J Physiol Pharmacol) Vol. 66 Issue 3 Pg. 246-9 (Mar 1988) ISSN: 0008-4212 [Print] Canada
PMID3383017 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Guanine Nucleotides
  • Receptors, Dopamine
  • Spiperone
  • Sodium
Topics
  • Animals
  • Binding, Competitive
  • Female
  • Guanine Nucleotides (physiology)
  • Neoplasm Transplantation
  • Pituitary Neoplasms (metabolism)
  • Rats
  • Rats, Inbred WF
  • Receptors, Dopamine (drug effects, metabolism)
  • Sodium (physiology)
  • Spiperone

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: